Clal Insurance’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23K Sell
52
-15
-22% -$7.05K ﹤0.01% 155
2026
Q1
$27K Sell
67
-4
-6% -$1.81K ﹤0.01% 148
2025
Q4
$33K Sell
71
-8
-10% -$3.55K ﹤0.01% 142
2025
Q3
$39K Buy
79
+19
+32% +$10.7K ﹤0.01% 139
2025
Q2
$31K Sell
60
-5
-8% -$2.33K ﹤0.01% 140
2025
Q1
$28K Buy
65
+53
+442% +$25.7K ﹤0.01% 142
2024
Q4
$6K Buy
+12
New +$6.27K ﹤0.01% 136

Other funds holding SNPS

Clal Insurance's SNPS Position: Q2 2026 in Review

Clal Insurance reduced its Synopsys (SNPS) stake by 22% in Q2 2026, selling an estimated $7.05K and leaving 52 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #155.

Clal Insurance first reported a position in SNPS in Q4 2024 and has held it in 7 quarters since. The position peaked at $39K in Q3 2025. 1,444 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Clal Insurance held 52 shares of Synopsys worth $23K as of Q2 2026.
  • Clal Insurance sold 15 Synopsys shares in Q2 2026, an estimated $7.05K.
  • Synopsys made up ﹤0.01% of Clal Insurance's portfolio in Q2 2026, its #155 holding.
  • Clal Insurance first reported a position in Synopsys in Q4 2024 and has held it in 7 quarters since.
  • Clal Insurance's Synopsys position peaked at $39K in Q3 2025.
  • 1,444 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.